Imiquimod
Essai thérapeutique en double aveugle versus placebo évaluant l'efficacité de l'imiquimod 5% crème sur l'infection péri-anale latente à papillomavirus humain (PVH) chez des patients infectés par le VIH.
20
10, 2002
20
10, 2002
1456 imiq
Etude ouverte, non-comparative, de phase IV exploratoire évaluant l'imiquimod crème à 5% dans le traitement des condylomes ano-génitaux externes chez des personnes séropositives et traitées par HAART.
20
10, 2002
Edito
Depuis le temps que nous le côtoyons le VIH ne nous a pas encore livrer tous ses secrets. Il reste encore énormément à apprendre : le fonctionnement du virus lui-même, les traitements disponibles, leurs effets secondaires, comment y remédier, comment mieux vivre physiquement, comment mieux vivre socialement, psychologiquement. Les associations ont toujours besoin de moyens financiers [...]
16
10, 2002
Coca-Cola laisse mourir ses employés séropositifs ; Act Up zappe Coca-Cola
Ce matin à 6 heures, une trentaine de militants d'Act Up-Paris ont fermé l'usine Coca-Cola de Grigny (91) et exigent de rencontrer Dominique REINICHE, PDG de Coca-Cola France et Benelux. Cette intervention d'Act Up-Paris entre dans le cadre de la journée mondiale d'action menée par une coalition internationale d1activistes exigeant de Coca-Cola la prise en charge [...]
14
10, 2002
October 16-17 : a global protest movement against Coca-Cola
An international coalition of AIDS activists, from Harare to Paris, from Casablanca to Atlanta, from Bangkok to New York, is organizing a global protest movement against Coca-Cola on October 16 and 17, 2002. This coalition has been demanding that Coca-Cola and other multinational corporations in developing countries provide medical treatment for all their workers living with [...]
14
10, 2002
AIDS in Africa : Coca-Cola Lets Its Workers Die
An international coalition of AIDS activists, from Harare to Paris, from Casablanca to Atlanta, from Bangkok to New York, is organizing a global protest movement against Coca-Cola on October 16 and 17, 2002. This coalition has been demanding that Coca-Cola and other multinational corporations in developing countries provide medical treatment for all their workers living with HIV/AIDS.
14
10, 2002
Problems with the Coke’s Initiative
- No medical care for family members other than employees and their spouses - Out-of-pocket costs for workers for the purchase of medicines will prove to be an unsurmountable barrier to access for most of them - No commitment to using the least costly medicines( generics instead of brand-name drugs) - No promise to sustain the [...]
14
10, 2002
Coca-Cola is Making Big Profits Thanks to African Workers
- Coca-Cola is the most important private sector employer in Africa : it employs 100 000 people to distribute Coca-Cola products in all African countries, except two. - In 2001 Coca-Cola's turnover in Africa reached $621 million and represented the highest growth rate of the company's sales in the world. The same year AIDS killed more [...]
14
10, 2002
Our Protest Movement
On October 16 and 17 protest actions against Coca-Cola will take place in many countries to denounce Coca-Cola's refusal to pay for the treatment of its employees. Demonstrations are planned in South Africa, Ghana, Nigeria, Zimbabwe, Morocco and other African countries as well as in Thailand, Canada, Portugal, Japan, Norway, India, Great Britain and the United [...]
14
10, 2002
Schering-Plough ment aux malades
Aujourd'hui, 14 octobre 2002, une vingtaine de militants d'Act Up-Paris ont investi les locaux de Schering-Plough à Levallois-Perret pour dénoncer le mépris du laboratoire vis-à-vis des patients co-infectés au VIH / sida et à l'hépatite C.